Page 14 - Laboratory Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Looking at here. it's a small study. they basically are measuring antibody levels. so, this is a laboratory study. so they're basically in the lab saying, okay, when we expose to this virus with this vaccine, how much antibodies do we get? how much do we get if we give a booster six months later. the antibodies increase nine fold compared to where they were 28 days after the first shot. so, that's a pretty significant increase. and i think it's probably going to be enough for johnson & johnson if this data is vetted and holds up to make the case that people should get boosters around the count...

California [US], August 8 (ANI): The findings of a new study suggest that a group of medications that have been long prescribed to treat tapeworm has inspired a compound that shows two-pronged effectiveness against COVID-19.

CDC scientists model the most efficient physical barrier against SARS-CoV-2 for worker protection Size doesn’t matter — when it comes to physical barriers in the workplace. A new Centers for Disease Control and Prevention (CDC) study found larger barriers were not statistically better than smaller physical barriers in protecting against severe acute respiratory syndrome 2 (SARS-CoV-2). SARS-CoV-2 spreads through the air, and new variants have made the virus even more transmissible. In response, many workplaces have erected physical and transparent barriers to block viral droplets. The res...

Not be as high, we'll see a lot of devastating illness, icus are filling up across the south. it is heartbreaking because none of the hospitalizations have to happen. almost all of these hospitalizations are preventable. >> let's talk about the study suggesting johnson & johnson vaccine may not be as effective against the delta variant. we mentioned where it is on timeline of the science, not peer reviewed or published in a medical journal. how seriously should we take it, how concerned should j&j recipients be about their level of protection from the delta variant? >> i think it is important ...

A top Pfizer Inc scientist says the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically targeted for a highly contagious variant that is spreading widely in SA and elsewhere.